Related Experiment Video
Updated: Aug 21, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
Cellular sources of new pancreatic beta cells and therapeutic implications for regenerative medicine
1Department of Genetic Medicine and Development, University Medical Centre, 1 rue Michel Servet, 1211 Geneva 4, Switzerland. philippe.halban@medecine.unige.ch
Abstract:
Replacing missing insulin-producing beta cells to treat diabetes is a major challenge for regenerative medicine. A better understanding of beta-cell embryogenesis and regeneration in adult life is needed to devise means to derive these specialized cells in sufficiently large numbers from stem or precursor cells. It is also critical to ensure that any surrogate or regenerated beta cells have perfectly regulated insulin production, which is essential for physiological glucose homeostasis.
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
iPS Cell Differentiation
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Stem Cell Culture

